Principal Investigator
Eugene Schiff
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240188
Clinical Trial Summary
Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Alcohol-related liver disease
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu